Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Betadex

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Betadex?

Betadex is an investigational drug.

There have been 8 clinical trials for Betadex. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2016.

The most common disease conditions in clinical trials are Schizophrenia, Psychomotor Agitation, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Bayer, Yang Fude, and Pfizer.

There are two US patents protecting this investigational drug and twenty-nine international patents.

Recent Clinical Trials for Betadex
Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440Janssen Research & Development, LLCPhase 1
A Study in Healthy Female Participants to Investigate the Effect of JNJ-56136379 at Steady-state on the Single-dose Pharmacokinetics of Ethinylestradiol and Drospirenone (Oral Contraceptive) and on the Single-dose Pharmacokinetics of Midazolam (ProbeJanssen Sciences Ireland UCPhase 1
The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic AgitationPfizerPhase 4

See all Betadex clinical trials

Clinical Trial Summary for Betadex

Top disease conditions for Betadex
Top clinical trial sponsors for Betadex

See all Betadex clinical trials

US Patents for Betadex

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Betadex   Start Trial Therapeutic and imaging compositions and uses thereof Purdue Research Foundation (West Lafayette, IN)   Start Trial
Betadex   Start Trial Hard coating composition LG CHEM, LTD. (Seoul, KR)   Start Trial
Betadex   Start Trial Therapeutic nuclease compositions and methods University of Washington (Seattle, WA)   Start Trial
Betadex   Start Trial Pharmaceutical composition for preventing or treating skin cancer comprising Panax spp. plant extract and method of preventing or treating skin cancer in a subject using the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, KR)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Betadex

Drugname Country Document Number Estimated Expiration Related US Patent
Betadex Canada 2911906 2033-05-07   Start Trial
Betadex European Patent Office 2994755 2033-05-07   Start Trial
Betadex World Intellectual Property Organization (WIPO) 2014182804 2033-05-07   Start Trial
Betadex China 104487494 2032-05-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.